Chong Lionel, Dushaj Nicholas, Rakoubian Ani, Yarbro Johnathan, Kobayashi Satoru, Liang Qiangrong
Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY 11568-8000, USA.
Int J Drug Discov Pharm. 2024 Sep;3(3). doi: 10.53941/ijddp.2024.100016. Epub 2024 Aug 26.
Cardiomyocytes are highly dependent on oxygen for optimal function. Disruption of oxygen availability, as in the case of ischemic heart disease, can significantly impair heart function. Moreover, comorbidities like diabetes, hyperlipidemia, and hypertension can exacerbate ischemic cardiac injury. However, cardiomyocytes possess inherent protective mechanisms that can be activated to enhance myocardial survival under such conditions. Understanding the functions and regulatory mechanisms of these cardioprotective genes is crucial for advancing our knowledge of cardiovascular health and for developing therapeutic strategies. This review examines the intricate mechanisms of cardioprotection, with a focus on key genes and proteins, including hypoxia-inducible factor-1 (HIF-1), heme oxygenase-1 (HO-1), glucose transporter 1 (GLUT-1), and GLUT-4. In addition, the review explores the roles and regulation of these factors in the heart under ischemic stress, shedding light on their relevance in conditions like diabetes, hypertension, and hyperlipidemia/atherosclerosis. Moreover, it highlights the complex interplay among their mechanisms and suggests opportunities for developing targeted therapiesfor the treatment of ischemic heart disease, hypertension, and hyperlipidemia.
心肌细胞的最佳功能高度依赖于氧气。如在缺血性心脏病中,氧供应中断会显著损害心脏功能。此外,糖尿病、高脂血症和高血压等合并症会加重缺血性心脏损伤。然而,心肌细胞具有内在的保护机制,在这种情况下可被激活以增强心肌存活能力。了解这些心脏保护基因的功能和调控机制对于增进我们对心血管健康的认识以及制定治疗策略至关重要。本综述探讨了心脏保护的复杂机制,重点关注关键基因和蛋白质,包括缺氧诱导因子-1(HIF-1)、血红素加氧酶-1(HO-1)、葡萄糖转运蛋白1(GLUT-1)和GLUT-4。此外,该综述还探讨了这些因子在缺血应激下在心脏中的作用和调控,阐明了它们在糖尿病、高血压和高脂血症/动脉粥样硬化等病症中的相关性。此外,它强调了它们机制之间的复杂相互作用,并提出了开发针对缺血性心脏病、高血压和高脂血症的靶向治疗方法的机会。